JONES LANG LASALLE INC
For the period ended Dec 31, 2025. Filed Feb 19, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Feb 19, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 9B. Other Information
On December 9, 2025, Deborah McAneny, a Director of the Company, entered into a pre-planned stock trading arrangement (the “McAneny Trading Plan”) designed to comply with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended, and the Company’s insider trading policy.
The McAneny Trading Plan provides for the sale of up to 3,352 shares of the Company’s common stock subject to certain price thresholds. Sales under the McAneny Trading Plan may commence no earlier than March 10, 2026, and will terminate on the earlier of December 9, 2026, or when all shares under the McAneny Trading Plan have been sold.
On December 19, 2025, the Company’s Chief Executive Officer Christian Ulbrich entered into a pre-planned stock trading arrangement (the “Ulbrich Trading Plan”) designed to comply with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended, and the Company’s insider trading policy.
The Ulbrich Trading Plan provides for the sale of up to 30,000 shares of the Company’s common stock subject to certain price thresholds and with no more than 2,000 shares being sold on any trading day. Sales under the Ulbrich Trading Plan may commence no earlier than June 17, 2026, and will terminate on the earlier of December 31, 2026, or when all shares under the Ulbrich Trading Plan have been sold.
On December 23, 2025, Anne Bloxam, thespouse of Richard Bloxam, the Company’s CEO of Capital Markets, entered into a pre-planned stock trading arrangement (the “Anne Bloxam Trading Plan”) designed to comply with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended, and the Company’s insider trading policy.
The Anne Bloxam Trading Plan provides for the sale of up to 5,440 shares of the Company’s common stock. Sales under the Anne Bloxam Trading Plan may commence no earlier than March 24, 2026, and will terminate on the earlier of June 18, 2026, or when all shares under the Anne Bloxam Trading Plan have been sold.
No other directors or officers adopted orterminated any contract, instruction or written plan for the purchase or sale of our securities that was intended to satisfy the affirmative defense conditions of a Rule 10b5-1(c) trading arrangement or a non-Rule 10b5-1 trading arrangement as such terms are defined under Item 1 408(a) or Regulation S-K during the quarter ended December 31, 2025.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.